Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Wells Fargo (NY:WFC)

88.71 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Wells Fargo

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Stock Market Today, Sept. 14: Bank of America Slides on Investment Banking Fee Surprise ↗
On Sept. 14, 2026, CEO Brian Moynihan flagged weaker trading performance and softer dealmaking fees, keeping investors focused on capital-markets sensitivity. 
Via The Motley Fool
Topics Stocks
News headline image
Wells Fargo Brings International Money Transfers to Mobile Banking
From Wells Fargo
Via Business Wire
News headline image
Veeva Systems Sees AI as Growth Engine Beyond Its $6B 2030 Revenue Target ↗
Veeva Systems (NYSE:VEEV) is positioning artificial intelligence as an incremental growth opportunity beyond its previously stated goal of reaching $6 billion in revenue by 2030, according to... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Got $1,000? Here's What an Intel Investment Made the Day the U.S. Government Took Its Stake Would Be Worth Today. ↗
It's been a profitable investment for Washington. 
Via The Motley Fool
Topics Artificial Intelligence Government
News headline image
Biogen Sees Pivotal Pipeline Moment as It Expands Beyond Neurology ↗
Biogen (NASDAQ:BIIB) executives said the company is focused on diversifying beyond its historical neurology concentration, advancing a broader late-stage pipeline and managing expenses as it seeks to... 
Via MarketBeat
News headline image
Vertex Pharmaceuticals Highlights Catalyst-Rich Pipeline Beyond Cystic Fibrosis ↗
Vertex Pharmaceuticals (NASDAQ:VRTX) highlighted a series of upcoming clinical, regulatory and commercial catalysts across renal disease, pain management, cystic fibrosis and endocrinology during a... 
Via MarketBeat
News headline image
Regeneron Eyes 2026 Catalysts as EYLEA HD and DUPIXENT Drive Growth ↗
Regeneron Pharmaceuticals (NASDAQ:REGN) executives outlined plans for continued growth across its commercial portfolio, upcoming regulatory milestones and pipeline programs during a Wells Fargo... 
Via MarketBeat
Topics ETFs
News headline image
Intuitive Surgical Sees Procedure Growth Despite U.S. Slowdown and China Pressure ↗
Intuitive Surgical (NASDAQ:ISRG) executives said the company remains focused on global procedure growth, while acknowledging a recent deceleration in U.S. procedures and policy-related uncertainty... 
Via MarketBeat
Topics Artificial Intelligence ETFs
News headline image
Amgen Highlights 26% Growth Drivers, IMDELLTRA Momentum and MariTide Potential ↗
Amgen (NASDAQ:AMGN) executives highlighted growth across its key commercial products, progress in late-stage development programs and a continued focus on profitability and cash returns during a Wells... 
Via MarketBeat
Topics ETFs
News headline image
RH Analysts Cut Price Targets After Q2 Results, But Estates Collection Could Fuel Growth ↗
RH analysts revised price targets after mixed second-quarter results, with TD Cowen, Wells Fargo, UBS and BofA Securities lowering their targets. 
Via Benzinga
News headline image
OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months ↗
OPKO Health (NASDAQ:OPK) outlined a strategy to shift its business mix toward therapeutics while continuing to streamline its diagnostics operations, with management highlighting a pipeline of... 
Via MarketBeat
News headline image
Caterpillar Sees Strong 2026 Start as Data Center Power Demand Fuels Expansion ↗
Caterpillar (NYSE:CAT) Chairman and CEO Joe Creed said the company has started 2026 with strong demand across its three operating segments, supported by power-generation activity, construction... 
Via MarketBeat
Topics Artificial Intelligence Energy
News headline image
Thermo Fisher, Wells Fargo, Nutrien And More On CNBC’s ‘Final Trades’ ↗
CNBC’s final trades: INFL, Wells Fargo, Nutrien and Thermo Fisher. Wells Fargo beat Q2 estimates; Nutrien missed earnings but topped sales. 
Via Benzinga
News headline image
Gilead Sciences Eyes HIV, Oncology Catalysts as Pipeline Enters Execution Mode ↗
Gilead Sciences (NASDAQ:GILD) Chief Medical Officer Dietmar Berger outlined the company’s priorities across HIV, oncology and inflammation at the Wells Fargo conference, describing a portfolio that has... 
Via MarketBeat
News headline image
CVS Still Sees 'High-Trend' Cost Growth; Oscar, UNH Stock Fall ↗
Here's why Oscar Health may be hardest hit from CVS' comments. 
Via Investor's Business Daily
News headline image
Johnson & Johnson Eyes High-End MedTech Growth as Cardiovascular Takes Center Stage ↗
Johnson & Johnson (NYSE:JNJ) MedTech Chairman Tim Schmid said the company remains confident it is delivering growth at the high end of its previously stated 5% to 7% operational market-growth range for... 
Via MarketBeat
Topics ETFs Economy
News headline image
AbbVie Highlights SKYRIZI, RINVOQ Growth and Pipeline Catalysts at Wells Fargo Conference ↗
AbbVie (NYSE:ABBV) executives outlined growth plans across immunology, oncology and neuroscience at a Wells Fargo conference, emphasizing continued momentum for its SKYRIZI and RINVOQ franchises, a... 
Via MarketBeat
News headline image
Editas Medicine Eyes First Human Trial for CRISPR Cholesterol Therapy EDIT-401 ↗
Editas Medicine (NASDAQ:EDIT) is preparing to begin a first-in-human study of EDIT-401, an in vivo CRISPR-edited medicine designed to lower LDL cholesterol in patients with heterozygous familial... 
Via MarketBeat
News headline image
Medtronic Touts AI, Robotics and Ablation Growth at Wells Fargo Conference ↗
Medtronic (NYSE:MDT) executives said the medical device maker is seeing accelerating growth across major franchises and emerging product categories, supported by innovation in artificial intelligence,... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates ↗
McKesson (NYSE:MCK) discussed its planned $2.25 billion acquisition of Precision Medicine Group, first-quarter operating trends and capital-allocation priorities during a presentation with Wells Fargo... 
Via MarketBeat
News headline image
Wells Fargo to Present at the Barclays Global Financial Services Conference
From Wells Fargo & Company
Via Business Wire
News headline image
Why Nutanix Stock Ascended in August ↗
It ended its latest fiscal year quite impressively. 
Via The Motley Fool
News headline image
Enhancing Comfort and Reliability: Plumbtech, LLC Expands Support for Local Property Owners With HVAC and Plumbing Services in Watertown, CT
Via GetFeatured
News headline image
Why Innodata Stock Tumbled by 10% Last Month ↗
It wasn't because of the quarterly earnings report it published that month. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
From Launch Party to Federal Probe: What Went Wrong With Tesla's Cybercab in 24 Hours ↗
The much-anticipated launch led to a share price plunge. 
Via The Motley Fool
News headline image
These Analysts Revise Their Forecasts On Phreesia After Q2 Results ↗
Phreesia's Q2 EPS missed estimates, while sales beat. FY27 guidance held; shares fell 5.6%. Analysts kept bullish targets, Wells Fargo raised to $10. 
Via Benzinga
Topics Earnings
News headline image
Right The 1st Time Marks 18 Years of Growth as Woman-Owned Company
Indianapolis, Indiana - September 02, 2026 - Right The 1st Time, the woman-owned residential cleaning company founded by Amy White in 2008, is marking its 18th year of operation and... 
Via Press Advantage
News headline image
Strikepoint Gold’s Blockbuster Deal with Newmont, CEO Interview ↗
In the past few months, investment banks have updated year end views on gold (“Au”) to US$4,500-$5,100/oz vs. the current price of ~$4,380. For example, Go 
Via Talk Markets
News headline image
Jax Humor: Best-Selling Jacksonville Stickers $9.04 on 904 Day
Via AB Newswire
News headline image
Socure Reaches $5.2 Billion Valuation and Acquires Fravity to Automate Fraud Operations ↗
Digital identity verification and fraud prevention provider Socure has achieved a $5.2 billion valuation and buys following a strategic growth investment l 
Via Talk Markets
Topics Artificial Intelligence Fraud
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.